D Goldwater
Pikesville, MDNPI 1891191755
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$12,455,851in research payments, 2019–2025
Across 127 payments — averaging $98,078 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$5.4M
- Viiv Healthcare Company$3.3M
- Vertex$1.8M
- Sanofi$1.8M
- Astellas US Technologies$135K
- AbbVie$21K
- plus $22K from 2 others
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.